Title or Question
Describe the item or answer the question so that site visitors who are interested get more information. You can emphasize this text with bullets, italics or bold, and add links.Title or Question
Describe the item or answer the question so that site visitors who are interested get more information. You can emphasize this text with bullets, italics or bold, and add links.Title or Question
Describe the item or answer the question so that site visitors who are interested get more information. You can emphasize this text with bullets, italics or bold, and add links.
New Title
About Us
Nayatt Advisors Global is a healthcare and biopharma consulting firm led by seasoned physicians and pharmacists who have been on the front lines of both clinical care and business leadership. Our unique blend of medical insight and strategic acumen allows us to bridge the critical gap between patient-centered practice and fiscal performance.
With decades of experience across healthcare systems, pharmaceutical R&D, and executive leadership, our team speaks the language of both care and capital. We don’t just understand your science — we know how to help you scale it, regulate it, fund it, and launch it with impact.
Whether you're a biotech startup, an established pharmaceutical firm, or a health system looking to optimize outcomes, we deliver smart, evidence-based strategies that respect the sensitivities of care while driving sustainable growth. From molecule to market, Nayatt is your partner in meaningful progress.
WORKING TOGETHER
At Nayatt Advisors Global, we offer end-to-end consulting solutions tailored to the unique challenges of healthcare, life sciences, and biopharma organizations. Our partnering services are built around one core principle: turning clinical complexity into business clarity.
01
Strategic Advisory
- Clinical-to-commercial strategy development
- Go-to-market planning for pharma and biotech
- Organizational transformation & change management
02
Scientific & Medical Expertise
- Medical affairs support & scientific communications
- Clinical trial strategy & protocol evaluation
- Regulatory guidance & submission planning
03
Financial & Operational Consulting
- Budget modeling & performance optimization
- Value proposition and pricing strategy
- Health economics & outcomes research (HEOR) alignment
04
Stakeholder Engagement
- KOL engagement strategy
- Patient advocacy integration
- Cross-functional leadership coaching
Past and Current Success
* Proven track record in hospital turnaround, delivering multi-million dollar budget recoveries, restoring operational health, and optimizing system-wide efficiency through rigorous Value Above Replacement (VAR) analyses. Our work has enabled sustainable financial and clinical improvements that directly support board-level strategic goals.
* Trusted by executive leadership teams, we specialize in high-impact healthcare turnaround—recovering multi-million dollar budgets, realigning clinical and financial operations, and delivering precise, actionable VAR analyses. Our strategic interventions position systems for long-term stability, growth, and measurable improvement in patient and fiscal outcomes.
* From pipeline to optimistic approval, we’ve supported successful drug development through high-level clinical analyses and regulatory writing services that meet FDA and global submission standards.
A Snapshot
15–25%
Improvement in hospital operating margins within 12–18 months
$5M–$20M
Recovered annually through better resource alignment, service line optimization, and waste reduction.
100%
Of all Biopharma engagements producing positive regulatory outcomes—driving submission readiness, de-risking development pipelines, and accelerating market access.
100%
Of regulatory submissions accepted for review
Commercial Strategy & Market Access
- Go-to-market and segmentation strategy
- Value proposition, pricing, and HEOR
- Market access roadmap (US and Global)
- Payer engagement and value messaging
- From innovation to impact — with a plan.
Our Principal Partners
A Glimpse Into Our Value Proposition Journey
Dr. Robert J. Weil
Weil R. How to 'engineer' for patient safety: 5 questions with CHI CMO Dr. Robert Weil. Becker's Hospital Review. Monday, February 13th, 2017. https://www.beckershospitalreview.com/hospital-management-administration/how-to-engineer-for-patient-safety-5-questions-with-chi-cmo-dr-robert-weil.html.
Weil R, Reichert J. Management guru’s wisdom more important than ever as healthcare strives to reward value. Modern Healthcare, August 14, 2017.
Marshall M, Merlino D, Weil R. What is the Value and Return of the Medical Group Enterprise? Becker’s ASC Review, October 18, 2019. (SRI) Available at: https://www.beckersasc.com/leadership-management/what-is-the-value-and-return-of-the-medical-group- enterprise.html.
Marshall MM, Weil RJ. Enterprise Solution (the value of the Medical Group Enterprise [MGE]): management keys tooptimizing MGE components across the enterprise). Group Practice Journal, November/December 2020.
Available at: https://www.amga.org/performance-improvement/publications/group-practice-journal/archives/2020/12.
Dr. Steven A. Toms
Coming soon
Dr. Dun N. Huynh
Coming soon